Source: Eur Respir J 2013; 41: 1252-1256
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Marc Miravitlles, Juan José Soler-Cataluña, Myriam Calle, Joan B. Soriano. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J 2013; 41: 1252-1256

Member's Comments

No comment yet.

Related content which might interest you: The future of disease monitoring and management: the homework for clinical researchers Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 903-908 Year: 2001 Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 243-244 Year: 2002 Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 Recommendations for epidemiological studies on COPD Source: Eur Respir J 2011; 38: 1261-1277 Year: 2011 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Chronic obstructive pulmonary disease (COPD) assessment service: guidelines for referral and accuracy of clinical assessment Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005 Translating research into practice: how are guidelines implemented? Source: Eur Respir J 2003; 21: 23S-29S Year: 2003 The effectiveness of anti-inflammatory therapy for chronic obstructive pulmonary disease complicated by ischemic heart disease (new medication - new opportunities) Source: International Congress 2014 – Comorbidities Year: 2014 Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006 Monitoring of COPD. A review of current guidelines‘ recommendations Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care Year: 2007 The Dutch multidisciplinary experience Source: Annual Congress 2007 - Primary care: delivering quality respiratory care in primary care: a multidisciplinary international perspective Year: 2007 Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations. Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Acute exacerbations of chronic obstructive pulmonary disease: current recommendations review and quality of evidence analysis. Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Some gender features of the chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD treatment Year: 2013 COPD exacerbations: definitions and classifications Source: Eur Respir J 2003; 21: 46S-53S Year: 2003 The hospital management of COPD exacerbations in the UK: does it conform to national guidance? Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 The minimal important difference of exercise tests in severe COPD Source: Eur Respir J 2011; 37: 784-790 Year: 2011